{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:05:37Z","timestamp":1761523537288,"version":"3.32.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.cvsm.2003.12.002","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:20Z","timestamp":1113836000000},"page":"669-691","source":"Crossref","is-referenced-by-count":19,"title":["Antifungals and their use in veterinary ophthalmology"],"prefix":"10.1016","volume":"34","author":[{"given":"Marnie M","family":"Ford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2003.12.002_BIB1","first-page":"1240","article-title":"Conjunctival fungal flora in horses, cattle, dogs, and cats","volume":"184","author":"Samuelson","year":"1984","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.cvsm.2003.12.002_BIB2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.2042-3306.1998.tb04469.x","article-title":"Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1987\u20131996)","volume":"30","author":"Andrew","year":"1998","journal-title":"Equine Vet J"},{"issue":"2","key":"10.1016\/j.cvsm.2003.12.002_BIB3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2460\/ajvr.1998.59.02.138","article-title":"Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis","volume":"59","author":"Brooks","year":"1998","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB4","series-title":"Basic science course notes","article-title":"Bacterial, fungal, and algal microbiology and the eye","author":"Ramsey","year":"2002"},{"issue":"3","key":"10.1016\/j.cvsm.2003.12.002_BIB5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0039-6257(88)90086-0","article-title":"Pharmacologic management of keratomycoses","volume":"33","author":"Johns","year":"1988","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01578527","article-title":"Alteration of ergosterol content and chitin synthase activity in Candida albicans","volume":"5","author":"Pesti","year":"1981","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB7","first-page":"318","article-title":"Mechanisms of resistance to azole antifungal compounds","volume":"1","author":"Marichal","year":"1999","journal-title":"Curr Opin Antiinfect Invest Drugs"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB8","first-page":"2","article-title":"Equine keratomycosis: clinical and laboratory findings in 23 cases","volume":"3","author":"Grahn","year":"1993","journal-title":"Prog Vet Comp Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.1989.03430050026017","article-title":"Pseudallescheria boydii keratomycosis in a horse","volume":"195","author":"Friedman","year":"1989","journal-title":"J Am Vet Med Assoc"},{"issue":"11","key":"10.1016\/j.cvsm.2003.12.002_BIB10","first-page":"1257","article-title":"Fusarium keratomycosis in the horse","volume":"68","author":"Mitchell","year":"1973","journal-title":"Vet Med Small Anim Clin"},{"issue":"Suppl 2","key":"10.1016\/j.cvsm.2003.12.002_BIB11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.2042-3306.1983.tb04578.x","article-title":"Microbial isolates of the normal equine eye","volume":"2","author":"Whitley","year":"1983","journal-title":"Equine Vet J"},{"issue":"6","key":"10.1016\/j.cvsm.2003.12.002_BIB12","first-page":"773","article-title":"Prevalence of ocular microorganisms in hospitalized and stabled horses","volume":"49","author":"Moore","year":"1988","journal-title":"Am J Vet Res"},{"issue":"7","key":"10.1016\/j.cvsm.2003.12.002_BIB13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2460\/javma.1995.207.07.0928","article-title":"Antibacterial susceptibility patterns for microbial isolates associated with infectious keratitis in horses: 63 cases (1986\u20131994)","volume":"207","author":"Moore","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB14","first-page":"182","article-title":"Equine fungal keratitis","volume":"22","author":"Ball","year":"2000","journal-title":"Compend Contin Educ Pract Vet"},{"issue":"6","key":"10.1016\/j.cvsm.2003.12.002_BIB15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.2042-3306.1995.tb04425.x","article-title":"Corneal stromal abscesses in the horse: a review of 24 cases","volume":"27","author":"Hendrix","year":"1995","journal-title":"Equine Vet J"},{"issue":"7","key":"10.1016\/j.cvsm.2003.12.002_BIB16","first-page":"936","article-title":"Equine keratomycosis","volume":"14","author":"Barton","year":"1992","journal-title":"Compend Contin Educ Pract Vet"},{"issue":"6","key":"10.1016\/j.cvsm.2003.12.002_BIB17","first-page":"600","article-title":"Bacterial and fungal isolates from Equidae with ulcerative keratitis","volume":"182","author":"Moore","year":"1983","journal-title":"J Am Vet Med Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.cvsm.2003.12.002_BIB18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.2042-3306.1983.tb04557.x","article-title":"Keratomycoses in 11 horses","author":"Beech","year":"1983","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.cvsm.2003.12.002_BIB19","first-page":"676","article-title":"Antifungal sensitivity testing for equine keratomycosis","volume":"46","author":"Coad","year":"1985","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2003.12.002_BIB20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2460\/javma.1998.213.01.105","article-title":"Clinical appearances, healing patterns, risk factors, and outcomes of horses with fungal keratitis: 53 cases (1978\u20131996)","volume":"213","author":"Gaarder","year":"1998","journal-title":"J Am Vet Med Assoc"},{"issue":"Suppl","key":"10.1016\/j.cvsm.2003.12.002_BIB21","first-page":"S595","article-title":"Corneal stromal abscess in two horses","volume":"6","author":"Sweeney","year":"1984","journal-title":"Compend Contin Educ Pract Vet"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB22","first-page":"19","article-title":"Therapeutic penetrating keratoplasty for deep corneal stromal abscesses in eight horses","volume":"7","author":"Whittaker","year":"1997","journal-title":"Vet Comp Ophthalmol"},{"issue":"5","key":"10.1016\/j.cvsm.2003.12.002_BIB23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0195-5616(00)05007-5","article-title":"Canine systemic fungal infections","volume":"30","author":"Krohne","year":"2000","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB24","series-title":"Textbook of veterinary internal medicine","first-page":"453","article-title":"Systemic mycoses","author":"Taboda","year":"2000"},{"issue":"7","key":"10.1016\/j.cvsm.2003.12.002_BIB25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2460\/javma.1996.209.07.1271","article-title":"Ocular blastomycosis in dogs: 73 cases, 108 eyes (1985\u20131993)","volume":"209","author":"Bloom","year":"1996","journal-title":"J Am Vet Med Assoc"},{"issue":"6","key":"10.1016\/j.cvsm.2003.12.002_BIB26","first-page":"423","article-title":"Disseminated blastomycosis with ocular involvement in a dog","volume":"97","author":"Gionfriddo","year":"2002","journal-title":"Vet Med"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2003.12.002_BIB27","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/clinids\/14.Supplement_1.S30","article-title":"Virulence properties and non-immune pathogenetic mechanisms of fungi","volume":"14","author":"Vartivarian","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2003.12.002_BIB28","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1093\/clinids\/14.Supplement_1.S130","article-title":"Laboratory evaluation of antifungal agents: a brief overview","volume":"14","author":"Rinaldi","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.mi.31.100177.001451","article-title":"Antifungal agents: recent developments","volume":"31","author":"Kobayashi","year":"1977","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev.mi.31.100177.000305","article-title":"Biosynthesis of polyene macrolide antibiotics","volume":"31","author":"Martin","year":"1977","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.8153622","article-title":"Human mycoses: drugs and targets for emerging pathogens","volume":"264","author":"Georgopapadakou","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB32","first-page":"784","article-title":"Pharmacokinetics and body fluid and endometrial concentrations of cephapirin in mares","volume":"47","author":"Brown","year":"1986","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.40.2.279","article-title":"Antifungal agents: chemotherapeutic targets and immunologic strategies","volume":"40","author":"Georgopapadakou","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.cvsm.2003.12.002_BIB34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/07357909909011729","article-title":"Antifungal and antiviral agents: a review","volume":"17","author":"Shuter","year":"1999","journal-title":"Cancer Invest"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB35","series-title":"Corneal disorders: clinical diagnosis and management","first-page":"345","article-title":"Antifungal agents","author":"O'Day","year":"1984"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB36","first-page":"423","article-title":"Two antifungal agents produced by soil actinomycete","volume":"112","author":"Hazen","year":"1950","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cvsm.2003.12.002_BIB37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2885.2003.00456.x","article-title":"Antifungal agents of use in animal health\u2014chemical, biochemical and pharmacological aspects","volume":"26","author":"Vanden Bossche","year":"2003","journal-title":"J Vet Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cvsm.2003.12.002_BIB38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0002-9394(71)90418-1","article-title":"Keratomycosis","volume":"71","author":"DeVoe","year":"1971","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s002530100822","article-title":"Antifungal antibiotics","volume":"58","author":"Gupte","year":"2002","journal-title":"App Microbiol Biotechnol"},{"year":"2002","series-title":"Veterinary drug handbook","author":"Plumb","key":"10.1016\/j.cvsm.2003.12.002_BIB40"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0195-5616(03)00035-4","article-title":"Update on canine and feline fungal diseases","volume":"33","author":"Kerl","year":"2003","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"Suppl S1","key":"10.1016\/j.cvsm.2003.12.002_BIB42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.suppl_1.31","article-title":"Overview of the lipid formulations of amphotericin B","volume":"49","author":"Dupont","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB43","series-title":"Small animal clinical pharmacology and therapeutics","first-page":"222","article-title":"Treatment of fungal infections","author":"Boothe","year":"2001"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jac\/44.2.151","article-title":"Current and future antifungal therapy: new targets for antifungal agents","volume":"44","author":"Andriole","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB45","series-title":"Mode of action of antifungal agents","first-page":"343","article-title":"The polyene macrolide antibiotics and 5-fluorocytosine: molecular actions and interactions","author":"Kerridge","year":"1984"},{"issue":"1","key":"10.1016\/j.cvsm.2003.12.002_BIB46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0749-0739(17)30698-3","article-title":"Rational selection of antimicrobial drugs for treatment of infections of horses","volume":"3","author":"Brumbaugh","year":"1987","journal-title":"Vet Clin North Am Equine Pract"},{"year":"1980","series-title":"Antimicrobial drug action","author":"Edwards","key":"10.1016\/j.cvsm.2003.12.002_BIB47"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB48","first-page":"223","article-title":"Antifungal agents used for deep-seated mycotic infections","volume":"58","author":"Hermans","year":"1983","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB49","series-title":"The pharmacologic basis of therapeutics","first-page":"1222","article-title":"Antimicrobial agents: miscellaneous antibacterial agents; antifungal and antiviral agents","author":"Sande","year":"1980"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10408418709104448","article-title":"Anti-candida drugs\u2014the biochemical basis for their activity","volume":"15","author":"Vanden Bosscle","year":"1987","journal-title":"CRC Crit Rev Microbiol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.34.2.183","article-title":"Amphotericin B: current understanding of mechanisms of action","volume":"34","author":"Brajtburg","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB52","first-page":"257","article-title":"How do the polyene macrolide antibiotics affect the cellular membrane properties?","volume":"864","author":"Bolard","year":"1986","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-9394(75)90468-7","article-title":"Keratomycosis in Wisconsin","volume":"79","author":"Chin","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB54","first-page":"81","article-title":"Mycotic infections of cornea (drug sensitivity study)","volume":"30","author":"Prasad","year":"1982","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB56","first-page":"781","article-title":"Mycotic keratitis in South-Florida: a review of thirty nine cases","volume":"89","author":"Jones","year":"1969","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB57","first-page":"190","article-title":"Medical treatment in keratomycosis","volume":"27","author":"Malik","year":"1979","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB58","series-title":"The cornea","first-page":"228","article-title":"Infectious diseases: fungal diseases","author":"Forster","year":"1987"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB59","first-page":"125","article-title":"Zur konservativen therapie der hypopyonkeratitis und des hornhautabszesses","volume":"163","author":"Boke","year":"1973","journal-title":"Klin Monatsbl Augenheilkunde"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB60","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9394(73)90752-6","article-title":"Successfully treated postoperative Candida parakrusei endophthalmitis","volume":"76","author":"Rosen","year":"1973","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB61","series-title":"Current clinical topics in infectious diseases","first-page":"19","article-title":"Current and future therapy of invasive fungal infections","author":"Andriole","year":"1988"},{"year":"1994","series-title":"Pocket guide to systemic antifungal therapy","author":"Andriole","key":"10.1016\/j.cvsm.2003.12.002_BIB62"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2003.12.002_BIB63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000310884","article-title":"Topical antimycotics in ophthalmology","volume":"211","author":"Behrens-Baumann","year":"1997","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB64","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF01962595","article-title":"Treatment of systemic fungal infections: recent progress and current problems","volume":"7","author":"Walsh","year":"1988","journal-title":"Eur Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB65","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1128\/AAC.42.6.1412","article-title":"Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations","volume":"42","author":"Johnson","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/168.1.195","article-title":"Nosocomial acquisition of Candida albicans: an epidemiologic study","volume":"168","author":"Vazquez","year":"1993","journal-title":"J Infect Dis"},{"issue":"Suppl B","key":"10.1016\/j.cvsm.2003.12.002_BIB67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/28.suppl_B.27","article-title":"Amphotericin B: an introduction","volume":"28","author":"Warnock","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB68","series-title":"Candidiasis: pathogenesis, diagnosis and treatment","first-page":"371","article-title":"Antifungal agents","author":"Bodey","year":"1993"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.1962.03050170001001","article-title":"The use of amphotericin B in man","volume":"180","author":"Andriole","year":"1962","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.cvsm.2003.12.002_BIB70","first-page":"1249","article-title":"Treatment of canine blastomycosis with amphotericin B and ketoconazole","volume":"184","author":"Legendre","year":"1984","journal-title":"J Am Vet Med Assoc"},{"issue":"11","key":"10.1016\/j.cvsm.2003.12.002_BIB71","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/archinte.1988.00380110049010","article-title":"Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation","volume":"148","author":"Branch","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB72","unstructured":"Wingard J. Conventional versus lipid formulations of amphotericin B. Presented at Focus on Fungal Infections\u2014VII, Imedex Inc. San Antonio, March 12\u201314, 1997."},{"issue":"12","key":"10.1016\/j.cvsm.2003.12.002_BIB73","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2460\/javma.1996.209.12.2073","article-title":"Use of an amphotericin B lipid complex for treatment of blastomycosis in dogs","volume":"209","author":"Krawiec","year":"1996","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB74","series-title":"Infectious diseases of the dog and cat","first-page":"357","article-title":"Antifungal chemotherapy","author":"Greene","year":"1998"},{"issue":"4","key":"10.1016\/j.cvsm.2003.12.002_BIB75","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1751-0813.1996.tb10003.x","article-title":"Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B","volume":"73","author":"Malik","year":"1996","journal-title":"Aust Vet J"},{"issue":"7","key":"10.1016\/j.cvsm.2003.12.002_BIB76","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2460\/javma.1995.207.07.0855","article-title":"Antimicrobial agents for treatment of infectious keratitis in horses","volume":"207","author":"Moore","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB77","first-page":"504","article-title":"Antibiotics and antifungal agents","volume":"3","author":"Leopold","year":"1964","journal-title":"Invest Ophthalmol"},{"year":"1983","series-title":"Ocular pharmacology","author":"Havener","key":"10.1016\/j.cvsm.2003.12.002_BIB78"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB79","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0966-842X(94)90618-1","article-title":"Molecular mechanisms of drug resistance in fungi","volume":"2","author":"Vanden Bossche","year":"1994","journal-title":"Trends Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2003.12.002_BIB80","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1439-0507.1998.tb00581.x","article-title":"Cytochromes P450 in fungi","volume":"41","author":"Vanden Bossche","year":"1998","journal-title":"Mycoses"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB81","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl S1","key":"10.1016\/j.cvsm.2003.12.002_BIB82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","article-title":"Amphotericin B: spectrum and resistance","volume":"49","author":"Ellis","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.cvsm.2003.12.002_BIB83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/mmy.38.1.293.304","article-title":"In vitro antifungal susceptibility methods and clinical implications of antifungal resistance","volume":"38","author":"Espinel-Ingroff","year":"2000","journal-title":"Med Mycol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CMR.1.2.187","article-title":"Overview of medically important antifungal azole derivatives","volume":"1","author":"Fromtling","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB85","series-title":"Infectious diseases of the dog and cat","first-page":"378","article-title":"Histoplasmosis","author":"Wolf","year":"1998"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB86","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4613-9547-8_12","article-title":"Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action","volume":"1","author":"Vanden Bossche","year":"1985","journal-title":"Curr Top Med Mycol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB87","series-title":"Sterol biosynthesis inhibitors","first-page":"79","article-title":"Mode of action of pyridine, pyrimidine and azole antifungals","author":"Vanden Bossche","year":"1988"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB88","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/0006-2952(83)90223-X","article-title":"Mode of insertion of miconazole, ketoconazole and deacylated ketoconazole in lipid layers","volume":"32","author":"Brasseur","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB89","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s100960000395","article-title":"The exciting future of antifungal therapy","volume":"19","author":"Neely","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB90","first-page":"303","article-title":"Ketoconazole: clinical pharmacology and therapeutic recommendations","volume":"188","author":"Moriello","year":"1986","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB91","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1054-3589(08)60129-5","article-title":"Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds and putative targets for antifungal drug development","volume":"44","author":"Groll","year":"1988","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB92","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/00362177385190321","article-title":"Mode of action of clotrimazole","volume":"11","author":"Iwata","year":"1973","journal-title":"Sabouraudia"},{"issue":"Suppl","key":"10.1016\/j.cvsm.2003.12.002_BIB93","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/clinids\/9.Supplement_1.S15","article-title":"Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models","volume":"9","author":"Van Cutsem","year":"1987","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.cvsm.2003.12.002_BIB94","first-page":"156","article-title":"Treatment of canine blastomycosis with ketoconazole","volume":"182","author":"Dunbar","year":"1983","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB95","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9394(86)90953-0","article-title":"Miconazole and ketoconazole a satisfactory first-line treatment for keratomycosis","volume":"101","author":"Fitzsimons","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB96","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-9394(14)76362-7","article-title":"Cryptococcus keratitis after keratoplasty","volume":"110","author":"Perry","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB97","series-title":"The pharmacological basis of therapeutics","first-page":"964","article-title":"Antiseptics and disinfectants; fungicides; ectoparasiticides","author":"Harvey","year":"1980"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB98","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9394(84)90239-3","article-title":"Penetrating keratoplasty for exogenous Paecilomyces keratitis followed by postoperative endophthalmitis","volume":"98","author":"Kozarsky","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB99","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0002-9394(84)90252-6","article-title":"Successful treatment of fungal keratitis caused by Paecilomyces lilacinus","volume":"98","author":"Minogue","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000310533","article-title":"Fungal keratitis due to Scopulariopsis brevicaulis in an eye previously suffering from herpetic keratitis","volume":"208","author":"Del Prete","year":"1994","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB101","first-page":"15","article-title":"Principles in the management of oculomycosis","volume":"79","author":"Jones","year":"1975","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1439-0507.1976.tb01447.x","article-title":"Keratomycosis","volume":"19","author":"Matsumoto","year":"1976","journal-title":"Mykosen"},{"issue":"6","key":"10.1016\/j.cvsm.2003.12.002_BIB103","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1939-1676.1996.tb02082.x","article-title":"Treatment of blastomycosis with itraconazole in 112 dogs","volume":"10","author":"Legendre","year":"1996","journal-title":"J Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2003.12.002_BIB104","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1939-1676.1994.tb03260.x","article-title":"Itraconazole for the treatment of histoplasmosis in cats","volume":"8","author":"Hodges","year":"1994","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB105","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/archopht.1979.01020020271017","article-title":"Intraocular penetration of miconazole in rabbits","volume":"97","author":"Foster","year":"1979","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.cvsm.2003.12.002_BIB106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5326\/15473317-33-2-139","article-title":"Primary cutaneous coccidioidomycosis and subsequent drug eruption to itraconazole in a dog","volume":"33","author":"Plotnick","year":"1997","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB107","first-page":"176","article-title":"Cataracts in dogs after long-term ketoconazole treatment","volume":"6","author":"Da Costa","year":"1996","journal-title":"Vet Comp Ophthalmol"},{"issue":"12","key":"10.1016\/j.cvsm.2003.12.002_BIB108","first-page":"2504","article-title":"Ketoconazole-induced changes in selected canine hormone concentrations","volume":"47","author":"Willard","year":"1986","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB109","series-title":"Chemotherapy of fungal diseases","first-page":"153","article-title":"Mode of action studies","author":"Polak","year":"1990"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB110","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis","volume":"30","author":"Rex","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB111","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1086\/313746","article-title":"Practice guidelines for the treatment of fungal infections. For the Mycosis Study Group. Infectious Diseases Society of America","volume":"30","author":"Sobel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB112","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/313747","article-title":"Practice guidelines for the treatment of coccidioidomycosis","volume":"30","author":"Galgiani","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.43.1.1","article-title":"Antifungal peptides: novel therapeutic compounds against emerging pathogens","volume":"43","author":"De Lucca","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB114","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1, 3-beta-D-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB115","unstructured":"Tang J, Parr JJ, Turner W, Debono M, Lagrandeur L, Burkhardt F, et al. LY303366: a noncompetitive inhibitor of (1, 3)-b-D-glucan synthases from Candida albicans and Aspergillus fumigatus [abstract 367]. Progr Abstr 33rd Intersci Conf Antimicrob Agents Chemother 1993:186."},{"key":"10.1016\/j.cvsm.2003.12.002_BIB116","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1099\/00221287-137-8-1805","article-title":"Structure activity relationships of the nikkomycins","volume":"137","author":"Decker","year":"1991","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB117","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.41.11.2326","article-title":"In vitro preclinical evaluation of studies with the echinocandin antifungal MK-0991 (L-743,872)","volume":"41","author":"Bartizal","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB118","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archsurg.1968.01330200022004","article-title":"Silver sulphadiazine: a new topical therapy for Pseudomonas in burns","volume":"96","author":"Fox","year":"1968","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.cvsm.2003.12.002_BIB119","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2460\/javma.1997.211.02.199","article-title":"Evaluation of itraconazole-dimethyl sulfoxide ointment for the treatment of keratomycosis in nine horses","volume":"211","author":"Ball","year":"1997","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(73)92576-2","article-title":"Antifungal activity of silver sulfadiazine","volume":"2","author":"Wlodkowski","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB121","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archsurg.1979.01370270051008","article-title":"Pharmacology of sulfadiazine silver: its attachment to burned human and rat skin and studies of gastrointestinal absorption and extension","volume":"114","author":"Harrison","year":"1979","journal-title":"Arch Surg"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB122","first-page":"82","article-title":"Topical therapy and the development of silver sulfadiazine","volume":"157","author":"Fox","year":"1983","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB123","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.72.3.192","article-title":"Topical silver sulphadiazine\u2014a new drug for ocular keratomycosis","volume":"72","author":"Mohan","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB124","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0002-9394(81)90063-5","article-title":"Miconazole therapy for keratomycosis","volume":"91","author":"Foster","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB125","first-page":"54","article-title":"The treatment of corneal ulcer with povidone-iodine (Betadine)","volume":"30","author":"Hale","year":"1969","journal-title":"NC Med J"},{"issue":"10","key":"10.1016\/j.cvsm.2003.12.002_BIB126","first-page":"855","article-title":"The use of povidone-iodine for treatment of fungi in rabbit eyes","volume":"4","author":"White","year":"1972","journal-title":"Ann Ophthalmol"},{"issue":"Suppl","key":"10.1016\/j.cvsm.2003.12.002_BIB127","first-page":"872","article-title":"A study of the potential effect of povidone-iodine solution in treating ocular fungal pathogens","volume":"37","author":"Bates","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB128","first-page":"370","article-title":"Fungal cell-wall synthesis: the construction of a biological structure","volume":"5","author":"Cabib","year":"1988","journal-title":"Microbiol Sci"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.55.1.1-20.1991","article-title":"Adherence and receptor relationships of Candida albicans","volume":"55","author":"Calderone","year":"1991","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.114.1.111","article-title":"The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle","volume":"114","author":"Shaw","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00284688","article-title":"Cloning of the chitin synthase 3 gene from Candida albicans and its expression during yeast-hyphal transition","volume":"241","author":"Sudoh","year":"1993","journal-title":"Mol Gen Genet"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB132","series-title":"Infectious diseases of the dog and cat","first-page":"391","article-title":"Coccidiomycosis","author":"Greene","year":"1998"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB133","first-page":"50","article-title":"New treatment of coccidiomycosis","volume":"14","author":"Bartsch","year":"1997","journal-title":"Vet Forum"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB134","first-page":"351","article-title":"Lufenuron: determination of antifungal activity in vitro and measurement of blood concentrations after oral administration in horses","volume":"6","author":"Scotty","year":"2003","journal-title":"Proc Amer Coll Vet Ophthalmol"},{"issue":"No. 15","key":"10.1016\/j.cvsm.2003.12.002_BIB135","first-page":"1","article-title":"Antifungal susceptibility testing\u2014committee report. Reference method for broth dilution antifungal susceptibility testing of yeast\u2014approved standard. 2nd edition","volume":"22","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2002","journal-title":"NCCLS Document M27\u2013A2"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB136","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CMR.6.4.367","article-title":"Antifungal susceptibility testing","volume":"6","author":"Rex","year":"1993","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.cvsm.2003.12.002_BIB137","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/40.5.611","article-title":"Echinocandins and pneumocandins\u2014a new antifungal class with a novel mode of action","volume":"40","author":"Denning","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.cvsm.2003.12.002_BIB138","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0891-5520(05)70398-6","article-title":"Clinical relevance of antifungal resistance","volume":"11","author":"Espinel-Ingroff","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB139","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"No. 15","key":"10.1016\/j.cvsm.2003.12.002_BIB140","first-page":"1","article-title":"Antifungal susceptibility testing\u2014committee report. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi\u2014approved standard. 2nd edition","volume":"22","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2002","journal-title":"NCCLS Document M38-A"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB141","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1128\/AAC.42.2.282","article-title":"Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models","volume":"42","author":"Odds","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"year":"1974","series-title":"Medical mycology: the pathogenic fungi and the pathogenic actinomycetes","author":"Rippon","key":"10.1016\/j.cvsm.2003.12.002_BIB142"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB143","series-title":"Infectious diseases of the dog and cat","first-page":"371","article-title":"Blastomycosis","author":"Legendre","year":"1998"},{"issue":"5","key":"10.1016\/j.cvsm.2003.12.002_BIB144","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2460\/javma.1998.213.05.658","article-title":"Blastomycosis in dogs: 115 cases (1980\u20131995)","volume":"213","author":"Arceneaux","year":"1998","journal-title":"J Am Vet Med Assoc"},{"issue":"69","key":"10.1016\/j.cvsm.2003.12.002_BIB145","first-page":"364","article-title":"Clinical aspects of mycotic keratitis in the horse","author":"Bistner","year":"1979","journal-title":"Cornell Vet"},{"key":"10.1016\/j.cvsm.2003.12.002_BIB146","first-page":"1207","article-title":"Antibacterial activity of dilute povidone-iodine solutions used for ocular surface disinfection in dogs","volume":"47","author":"Roberts","year":"1986","journal-title":"Am J Vet Res"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561603001803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561603001803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:08:54Z","timestamp":1735672134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561603001803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0195561603001803"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2003.12.002","relation":{},"ISSN":["0195-5616"],"issn-type":[{"type":"print","value":"0195-5616"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}